Assessing Novartis (SWX:NOVN) Valuation After Recent Mixed Share Price Performance [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Why Novartis Stock Is On Investors' Radar Novartis (SWX:NOVN) has attracted attention after recent share moves, with the stock near CHF 119 and mixed performance over the past month and past 3 months. This has prompted closer scrutiny from income and growth focused investors. See our latest analysis for Novartis. While the share price is around CHF 119.14 after a recent 7 day share price return of 3.06% and a 30 day share price return decline of 8.21%, the longer term picture is stronger, with a 1 year total shareholder return of 24.48% and a 5 year total shareholder return of 86.34%, suggesting momentum has been building over time. If Novartis has you looking more closely at healthcare opportunities, it could be worth scanning other names benefiting from medical and AI advances through our 126 healthcare AI stocks With Novartis trading near CHF 119, a value score of 5, an indicated intrinsic discount of about 60% and only a small gap to analyst targets, investors are left
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Radioligand Therapy Market Expected to Surge to $10.72 Billion by 2030: Upsurge in Cancer Cases Fuelling Industry Growth at 10% CAGR [Yahoo! Finance]Yahoo! Finance
- Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE-IgAN Study [Yahoo! Finance]Yahoo! Finance
- AAVantgarde appoints Philip Lao as Senior Vice President of Business Development [Yahoo! Finance]Yahoo! Finance
- The Vanguard ETF Up About 28% in the Past Year That Almost Nobody Outside of Income Investors Knows [Yahoo! Finance]Yahoo! Finance
- AAVantgarde appoints Philip Lao as Senior Vice President of Business Development [TheStreet.com]TheStreet.com
NVS
Earnings
- 2/4/26 - Beat
NVS
Sec Filings
- 3/18/26 - Form 6-K
- 3/17/26 - Form FWP
- 2/12/26 - Form 144
- NVS's page on the SEC website